By establishing expected GA levels from HbA1c, we could get additional information on the glycemic fluctuation, insulin secretory dysfunction and pro-atherogenic condition in subjects with T2D in whom the laboratory levels of GA would be above the calculated GA levels. This evidence concerns the gene INS and type 2 diabetes mellitus.